A 6 Week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Subjects With Hypercholesterolemia

Trial Profile

A 6 Week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Subjects With Hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2006

At a glance

  • Drugs Rosuvastatin (Primary) ; Atorvastatin; Pravastatin; Simvastatin
  • Indications Hypercholesterolaemia; Hypertriglyceridaemia; Metabolic syndrome
  • Focus Therapeutic Use
  • Acronyms STELLAR
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top